eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


4/2003
vol. 2
 
Share:
Share:
abstract:

Progestins in hormonal replacement therapy and contraception

Andrzej Mazurek
,
Paweł Kuć
,
Tadeusz Laudański

(Prz Menopauz 2003, 4: 40–45)
Online publish date: 2003/08/26
View full text Get citation
 
Progestins consist of a group of chemical substances which by different individual mechanisms exert various biological effects of progesterone. Progestins play a major role in the treatment of sterility and high-risk pregnancy and are main components of oral contraceptives (OC) and hormonal replacement therapy (HRT). The observational studies and randomized trials delivered an important insight into the side-effects of hormonal therapy. It is not only estrogen but also progestin component of oral contraception and hormonal replacement therapy which is now emphasized as a major contributory factor to cardiovascular and central nervous system as well as blood coagulation disorders and lipid and glucose metabolism malfunction. To obviate progestins side-effects risk, an individual course of hormonal therapy for each woman should be prescribed by a gynecologist. Therefore a choice of hormonal preparation, a dose of components and route of drug application should be based on the patient’s age, anamnesis and physical examination. Concomitant disorders and inherited susceptibility to some diseases should also be considered. The decision as to the hormonal therapy should be made by both a doctor and a patient.
keywords:

progestins, hormonal replacement therapy, contraception, menopause

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.